ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0365

Collapsing Glomerulopathy Associated with Diffuse Large B-Cell Lymphoma Causing Nephrotic Syndrome and AKI

Session Information

Category: Glomerular Diseases

  • 1401 Glomerular Diseases: Mechanisms, including Podocyte Biology

Authors

  • Shahid, Shahzad, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Khan, Inam Ullah, Bahria University, Karachi, Sindh, Pakistan
  • Khan, Maida, Services Hospital Lahore, Lahore, Punjab, Pakistan
  • Velagapudi, Ramya Krishna, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Arwani, Suneel, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Yunas, Samia, The University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Abro, Sheeraz G., The University of Mississippi Medical Center, Jackson, Mississippi, United States
Introduction

Collapsing glomerulopathy is an aggressive podocytopathy causing rapid kidney function decline and severe nephrotic syndrome. It is commonly linked to viral infections, autoimmune disease, medications, and APOL1 risk variants, while malignancy-associated cases are rare.

Case Description

An 84-year-old woman with CKD stage 3A, hypertension, and paroxysmal atrial fibrillation presented with dyspnea, poor intake, and syncope requiring cardioversion for atrial fibrillation with rapid ventricular response. Hospitalization was complicated by rapidly progressive acute kidney injury and nephrotic syndrome, with serum creatinine rising from 0.9–1.0 to 7.48 mg/dL and urine protein-creatinine ratio increasing from 1.35 to 64 g/g. Laboratory evaluation showed hypoalbuminemia, hypertriglyceridemia, hematuria, pyuria, granular casts, and dysmorphic red blood cells. Autoimmune, infectious, and paraprotein serologic workup was negative.

Kidney biopsy demonstrated acute tubular injury with collapsing focal segmental glomerulosclerosis, negative immunofluorescence, and diffuse podocyte foot process effacement on electron microscopy, consistent with collapsing glomerulopathy. Genetic testing identified a heterozygous APOL1 G2 allele, sickle cell trait, and likely pathogenic CASR variant.

Further evaluation revealed gastric diffuse large B-cell lymphoma with stage IV-E disease. Suspected paraneoplastic collapsing glomerulopathy prompted deferral of immunosuppression and initiation of mini R-CHOP chemotherapy. Renal function improved markedly without dialysis, with creatinine returning near baseline and proteinuria decreasing to 2.52 g/g after treatment.

Discussion

Collapsing glomerulopathy is a severe podocytopathy with poor renal outcomes and frequent progression to kidney failure. In this case, rapid nephrotic syndrome onset, negative serologies, biopsy findings, and improvement after lymphoma therapy supported a paraneoplastic mechanism and the need to evaluate for occult malignancy.

Collapsing glomerulopathy,foot process effacement